18 research outputs found

    Subcellular localization of VSV M proteins.

    No full text
    <p>BHK-T7 cells were transfected for 2 h with pTM1 encoding VSV M1 (A-D), M2 (E-F) or M3 (G-H), and fixed 6 h later. Expression and localization of viral proteins were analyzed by immunofluorescence using specific monoclonal antibodies against M1 that also recognize M2 and M3, and the corresponding mouse secondary antibody conjugated to Alexa 488. Localization of M1 in intracellular membranes and dot-like structures at the nuclear envelope or at the cell surface is shown in panels A, B and C, respectively. Localization of M2 and M3 in intracellular compartments (E and G) or surrounding the nucleus (F and H) is shown. Images were acquired with an Axiovert microscope connected to a digital camera.</p

    Effect of VSV M2 and M3 expression on nucleus-cytoplasm transport of mRNAs.

    No full text
    <p>BHK-T7 cells were transfected for 2 h with pTM1 empty (mock) or pTM1 encoding M1, M2 or M3 proteins. Cells were fixed 6 hpt and <i>in situ</i> hybridization with fluorescein-labeled oligo (dT) probe was carried out to detect cellular mRNAs. VSV M proteins were visualized by immunofluorescence using specific monoclonal antibodies against M1 (αM) and the corresponding mouse secondary antibody conjugated to Alexa 555. To-Pro3 was used as a nuclear marker. Images were acquired with a confocal microscope. Merged images are shown on the right.</p

    Induction of vesicle budding from the plasma membrane by VSV M proteins.

    No full text
    <p>BHK-T7 cells were transfected for 2 h with pTM1 encoding M1 (A-F), pTM1 empty (G), M2 (H) or M3 (I). Cells were fixed 6 h after transfection and immunodetection of VSV M proteins was performed using specific monoclonal antibodies and the corresponding mouse-secondary antibodies coupled to gold particles. Cells were visualized with a transmission electron microscope. Arrows indicate sites of vesicle budding at the plasma membrane (A-E) where M1 protein is concentrated, as well as vesicles already released from the cells (F). Statistical analyses of the gold granules distribution was carried out by unpaired (two-tailed) Student <i>t</i>-test. p < 0.01 using the Stata Program Version 11.0.</p

    VSV M proteins do not alter cell membrane permeability.

    No full text
    <p>(A) BHK-T7 cells were transfected with pTM1 empty plasmid or pTM1 constructs encoding M1, M2 or M3 proteins. As a positive control, cells were transfected with pTM1-2B (encoding poliovirus 2B viroporin). The medium was removed 2 h later and fresh DMEM containing 5% FCS was added. Cells were pre-treated 15 h after transfection with 0.5 mM of the translation inhibitor hygromycin B (HB) for 15 min. Then, cells were metabolically labelled with [<sup>35</sup>S]Met/Cys for 45 minutes in the presence or absence of HB. Samples were processed by SDS-PAGE (17.5%), fluorography and autoradiography. (B) BHK-21 cells were mock transfected or electroporated with SV-derived mRNA replicons: Rep C, Rep C+M1 or Rep C+6K, obtained by <i>in vitro</i> transcription from their corresponding DNA templates. Cells were pre-treated with HB and metabolically labeled as indicated in (A). Numbers below each lane indicate the percentages of protein synthesis calculated by dividing the densitometric values for HB-treated cells by the values for untreated cells. A cellular protein band in mock transfected cells, or the band corresponding to the SV C protein in replicon transfected cells, was quantified by densitometric scanning, respectively. Bands corresponding to SV C and VSV M1 protein are indicated with arrows. Detection of α-tubulin served as loading control.</p

    Cytotoxic effect mediated by expression of VSV M proteins.

    No full text
    <p>BHK-T7 cells were transfected with pTM1 empty (mock), pTM1-M1, pTM1-M2 or pTM1-M3 for 2 h. Cells were then washed and incubated in DMEM containing 5% FCS until they were fixed at 6, 18 and 24 h post transfection (hpt). Cell morphology was examined with a phase-contrast microscope.</p

    Validation of the typology found: differences between the three types of batterers in number of prior arrests, family and social variables and psychoactive substance consumption.

    No full text
    <p>Note. The data refer to the mean ± standard deviation (<i>SD</i>).</p><p>*<i>p</i><0.05 **<i>p</i><0.01 ***<i>p</i><.001.</p><p>High, moderate and low level of violence and psychopathology</p><p>Validation of the typology found: differences between the three types of batterers in number of prior arrests, family and social variables and psychoactive substance consumption.</p

    Differences between the three types of batterers in variables related to generality of violence and presence of psychopathology.

    No full text
    <p>Note. The data refer to the mean ± standard deviation (<i>SD</i>).</p><p>*<i>p</i><0.05 **<i>p</i><0.01 ***<i>p</i><.001.</p><p>High, moderate and low level of violence and psychopathology</p><p>Differences between the three types of batterers in variables related to generality of violence and presence of psychopathology.</p

    Comparison between batterers’ profiles obtained in this study and Cavanaugh and Gelles [11] proposal.

    No full text
    <p>Comparison between batterers’ profiles obtained in this study and Cavanaugh and Gelles <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0110651#pone.0110651-Cavanaugh1" target="_blank">[11]</a> proposal.</p

    Differences between the three types of batterers regarding the frequency of violence towards the partner.

    No full text
    <p>Note. Data refer to the average of episodes in the last year of cohabitation with the partner ± standard deviation (<i>SD</i>).</p><p>*<i>p</i><0.05 **<i>p</i><0.01 ***<i>p</i><.001.</p><p>High, moderate and low level of violence and psychopathology</p><p>Differences between the three types of batterers regarding the frequency of violence towards the partner.</p

    HAV IRES translation in BHK cells after cleavage of eIF4G.

    No full text
    <p>A) BHK-T7 cells were transfected or co-transfected for 2 h with 1 µg plasmid encoding HAV(IRES)-luc alone or in presence of 1 µg pTM1-2A or pFMDV-L, respectively. After 2 hpt, cells were treated with 200 µM Ars for 15 min and then metabolically labeled with 0.2 µCi per well [<sup>35</sup>S]Met/Cys in presence (+) or absence (−) of Ars for 45 min. Finally, cells were processed by SDS-PAGE, fluorography and autoradiography. B) The same samples were used to analyze eIF4GI, eIF2α phosphorylation and total eIF2α by western blot using specific antibodies as detailed in Materials and Methods. C) BHK-T7 cells were transfected under the conditions described above. Cells were then collected and processed to assay for luc activity as described in Materials and Methods. The bars represent the luc activity in presence (+) or absence (−) of Ars. The RLUs values obtained were as follows: pHAV-luc in absence (−) or presence (+) of Ars were 3.9×10<sup>5</sup> and 1.8×10<sup>5</sup>, respectively. pHAV-luc co-transfected with pTM1-2A (−) or (+) Ars were 0.2×10<sup>5</sup> and 0.1×10<sup>5</sup>, respectively, and finally pHAV-luc co-transfected with pFMDV-L (−) or (+) Ars were 25×10<sup>5</sup> and 17×10<sup>5</sup>, respectively. Error bars indicate standard deviation (SD). D) BHK-T7 cells were transfected with cap-luc, HAV(IRES)-luc or PV(IRES)-luc mRNAs. At 2 hpt cells were collected and luc activity was measured. The RLUs values obtained were as follows: cap-luc: 1.13×10<sup>6</sup>; HAV(IRES)-luc:1.46×10<sup>6</sup> and PV(IRES)-luc: 0.44×10<sup>6</sup>.</p
    corecore